Injective climbs 5.78%, eyes $60 target as SEC registration and AI integration advance

Liquidity zone sparks bullish momentum

Muted market sentiment and an extended period of sideways trading have placed the zone on the radar of both retail and institutional traders. Some anticipate that a confirmed breakout above resistance could set the stage for a sustained upward trend in INJ, especially as broader crypto markets stabilize.

While analysts remain cautious about extrapolating from past rallies, they suggest that breaking current resistance levels could move INJ towards the $60 mark if momentum builds and consolidation resolves in favor of buyers.

Institutional and AI-driven growth

Beyond price action, Injective has strengthened its position through advancements in real-world asset (RWA) tokenization, artificial intelligence integration, and regulatory steps that enhance appeal for institutional finance.

Recent progress includes partnerships with global conglomerates POSCO International and LG CNS, which piloted RWA applications by tokenizing trade data and commercial invoices. These pilots leveraged artificial intelligence to analyze letters of credit, while compliance features were embedded directly into the blockchain infrastructure.

Injective has also registered with the US Securities and Exchange Commission (SEC) as a transfer agent, increasing its ability to operate within regulated US financial markets. This regulatory move is designed to boost confidence among institutional clients and facilitate a wider range of tokenized assets on the network.

The blockchain’s diverse asset tokenization capabilities already encompass institutional assets, public stocks, trade receivables, and pre-IPO offerings. Firms such as SpaceX and OpenAI have reportedly utilized these services, underscoring Injective’s expanding ecosystem.

Mini dictionary: Real-world asset (RWA) tokenization enables tangible assets, such as real estate or invoices, to be represented as digital tokens on a blockchain, increasing liquidity and transparency for investors.

Analysts caution that future price action will depend on whether Injective can maintain buying pressure and decisively overcome resistance levels. Successful breakout scenarios are likely to accelerate momentum, while renewed consolidation could delay further gains.

Ongoing development in RWA tokenization, artificial intelligence applications, and enhanced regulatory infrastructure continues to position Injective as a platform of interest for both institutional and retail participants in the DeFi sector.